se of dexmedetomidine for pain relief after cesarean section.
Not Applicable
Completed
- Conditions
- Health Condition 1: O80- Encounter for full-term uncomplicated delivery
- Registration Number
- CTRI/2019/09/021394
- Lead Sponsor
- All India Institute of Medical Sciences Bhubaneswar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 70
Inclusion Criteria
ASA II females with normal singleton pregnancies with a gestation of >= 37 weeks, and scheduled for Caesarean Section under spinal anaesthesia.
Exclusion Criteria
1. High risk pregnancies and acute emergencies
2. Patients whose height < 145 cm
3. Patients with known allergy to study drugs (bupivacaine and dexmedetomidine)
4. Patients with contraindications to spinal anaesthesia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the time to the first request of rescue analgesia during postoperative period among the two groups receiving QL blocks with or without dexmedetomidine in first 24 hrs.Timepoint: To compare the time to the first request of rescue analgesia during first 24 hrs of postoperative period among the two groups receiving QL blocks with or without dexmedetomidine.
- Secondary Outcome Measures
Name Time Method To compare the number of doses of rescue analgesia, Numeric rating scale (NRS)for pain, Ramsay sedation score and patient satisfaction in first 24 hr.Timepoint: first 24 hr post operative period.